Veterinary Vaccine Market By Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines, Others), By Route of Administration (Oral, Parenteral, Intranasal, Topical), By Animal Type (Livestock, Companion, Aquaculture), By Region And Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, And Forecast 2023-2032

Report Overview

Veterinary Vaccine Market size is expected to be worth around USD 15.6 Bn by 2032 from USD 9.5 Bn in 2022, growing at a CAGR of 5.2% during the forecast period from 2023 to 2032.

The Veterinary Vaccine Market, an ever-expanding sector that encompasses the development, production, and distribution of vaccines for animals, experiences exponential growth due to the rising demand for food safety and animal welfare. In the coming years, the Veterinary Vaccine Market will endeavor to combat diseases in animals and improve the overall health of animals, thereby boosting farmers' productivity and increasing the animal industry's profitability.

The ability of the Veterinary Vaccines Market to combat the spread of diseases while simultaneously reducing the overuse of antibiotics, which can be detrimental to both animals and humans, is a key advantage of this market. Recombinant vaccines, a novel class that transcends conventional vaccines in terms of cost-effectiveness and safety, are the result of ground-breaking advances. Companies of eminence in the pharmaceutical industry have made substantial investments in the Veterinary Vaccine Market, incorporating these cutting-edge vaccines into their comprehensive portfolio of products and services.

The Veterinary Vaccine Market growth is supported by a variety of industries with a strong interest in animal health, such as agriculture, biotechnology, and pharmaceuticals. In addition to an ever-increasing demand for livestock products and dairy products, stringent regulations governing animal health and food safety contribute to the industry's expansion. The global rise in demand for animal products has led to an increase in livestock production worldwide. In the veterinary vaccine market, continual development for livestock vaccines aims to improve disease control and overall animal health.

Nevertheless, the rapid expansion of the Veterinary Vaccines Market raises ethical concerns and imposes the obligation to ensure transparency, explicability, and accountability. To ensure the safety and efficacy of vaccines, adherence to stringent regulations and guidelines becomes essential. Companies in the Veterinary Vaccine industry must operate ethically and responsibly, considering the welfare of animals and the conservation of the environment. Starting in July 2023, Rosselhoznadzor will require all imported poultry vaccine strains to be housed exclusively in Russian scientific facilities, ensuring domestic control over biosecurity.

The Veterinary Vaccine Market has an abundance of commercial applications. Vaccines can be utilized by animal health businesses, for instance, to treat and prevent diseases in livestock, thereby increasing the profitability and productivity of producers. Pharmaceutical companies can use vaccines as a springboard to develop novel animal-specific drug therapies, whereas biotech companies can use vaccines to establish new frontiers in animal health research and technology.

Driving Factors

Rise in Animal Diseases

The prevalence of animal diseases such as foot-and-mouth disease, avian influenza, and swine flu has been a major factor propelling the Veterinary Vaccine Market growth. Demand for vaccines has been fueled by the need to prevent and control these diseases. The veterinary vaccine market witnessed a surge due to increasing interest in distemper prevention. The Veterinary Vaccine's largest market share reflects the rising demand for meat, with key trends and key developments driving industry growth, particularly in animal vaccine advancements.

The Veterinary Vaccine market in the swine sector is experiencing remarkable growth, as swine producers recognize the critical importance of vaccines for swine health. These vaccines are indispensable tools in safeguarding against diseases that can devastate swine populations. Swine producers are increasingly prioritizing vaccination programs to protect their herds from various diseases, ensuring the well-being of their animals and maintaining profitability. In recent years, outbreaks of diseases-affected swine have underscored the urgency of vaccination. This has led to a surge in demand for vaccines tailored to the specific needs of the swine industry, driving innovation and expansion within the veterinary vaccine market for swine.

Government Initiatives and Regulations

Governments throughout the world have enacted regulations and implemented programs to ensure animal health, food safety, and disease control. The growth of the Veterinary Vaccine Market has been fueled by encouraging policies, funding initiatives, and vaccination requirements.

Growing Livestock and Companion Animal Population

Consumption of meat, milk, and eggs, has increased due to the growing global population and rising disposable incomes. This has increased the demand for animal vaccines to protect the health and productivity of livestock animals. In addition, the rising popularity of pet ownership has increased the demand for vaccines for companion animals.

Restraining Factors

High Costs of Vaccine Development

Veterinary vaccines incur significant research and development expenses. Due to the need for extensive testing, regulatory compliance, and quality control measures, vaccine development is a capital-intensive endeavor. These expensive costs can be prohibitive, especially for smaller market participants.

Regulatory Challenges

To ensure safety and efficacy, the Veterinary Vaccine Market is subject to stringent regulations and approval procedures. These regulatory obstacles can cause delays in vaccine development and market entry, inhibiting market expansion.

Limited Access to Veterinary Services

There is limited access to veterinary services and infrastructure in certain regions, particularly rural areas and developing nations. This hinders the distribution and administration of vaccines, thereby impeding market expansion.

Vaccine Storage and Cold Chain Requirements

Numerous veterinary vaccines necessitate specific storage conditions and a well-maintained cold chain in order to maintain their efficacy. In regions with insufficient cold chain infrastructure or unreliable electricity supply, maintaining proper storage conditions for vaccines becomes difficult, thereby reducing their efficacy.

Ethical and Public Perception Concerns

Animal testing and the use of genetically modified organisms present ethical concerns for the Veterinary Vaccine Market. Market acceptance and consumer preferences can be affected by public perception and ethical considerations, posing difficulties for certain vaccine types.

Type of Vaccine Analysis

Live Attenuated Vaccines Segment Dominates the Veterinary Vaccine Market. The market for animal vaccines has grown steadily over time, primarily as a result of increased awareness of vaccination's role in animal health management. The live attenuated vaccines segment has dominated the market in recent years, and this trend is anticipated to continue in the foreseeable future. In order to create live attenuated vaccines, the disease-causing pathogen is weakened so that it is still viable but unable to cause severe infectious diseases. This form of vaccine confers durable and cost-effective immunity to animals.

Emerging economies' growth is one of the most significant drivers of the live attenuated vaccines market. As China and India continue to experience rapid economic development, they are also experiencing a surge in demand for animal protein products. This has increased the need for animal health management, such as vaccination, to prevent the proliferation of diseases and their negative impact on the economy. In addition, as the middle class in these nations expands, they spend more on pet care and veterinary services, resulting in an increase in vaccine demand.

Route of Administration Analysis

The oral segment of the veterinary vaccine market is the most prevalent route of administration, accounting for the majority of demand, market share, and revenue growth. Oral vaccines are preferred due to their convenience, safety, and capacity to stimulate both mucosal and systemic immunity.

The adoption of oral vaccines is primarily driven by the economic growth of emerging economies, which has increased demand for animal protein products. Oral vaccines are preferred because they are simpler to administer, thereby reducing labor costs and increasing productivity, which are crucial in intensive livestock production. The adoption of vaccination within the veterinary vaccine market has emerged as a pivotal aspect of disease prevention and herd health management.

Consumers are increasingly concerned about animal welfare, and as a result, they favor vaccination methods that are less invasive and cause animals minimal discomfort or stress. These consumer preferences coincide with the convenience and safety of oral vaccines, resulting in increased demand for these vaccines. In the Veterinary Vaccine Market, the oral route is becoming increasingly prominent due to its convenience and efficiency in delivering vaccines to animals. The common routes in the Veterinary Vaccine industry encompass stages such as research and development, regulatory clearance, manufacturing, and distribution of vaccines designed to prevent and manage animal diseases.

Disease Type Analysis

Foot and mouth disease is a highly contagious viral infection that affects livestock such as cattle, piglets, and sheep. Reduced milk and livestock production, as well as international trade restrictions imposed on infected nations, result in severe economic losses. Vaccination is an indispensable instrument for controlling and preventing the disease's spread, making the foot and mouth disease segment the leading segment in the veterinary vaccine market.

The growth of the foot-and-mouth disease segment is driven by economic development in emerging economies, where disease outbreaks have resulted in significant economic losses. To control the disease's spread, governments have increased their vaccination programs, resulting in a rise in demand for foot and mouth disease vaccines. The veterinary vaccine market experiences steady growth as government agencies promote pet adoption, reducing the pet population, and preventing bacterial infections in animals.

Consumers and governments around the world are becoming more aware of animal welfare and disease prevention, resulting in an increase in demand for vaccines that reduce disease transmission and improve animal health. The segment's emphasis on one of the most economically significant animal diseases has increased the demand for vaccines.

Animal Type Analysis

The livestock segment dominates the veterinary vaccine market, during the forecast period generating the vast majority of demand, and revenue share. Cattle, sheep, and pigs, among others, are significant sources of food and income for farmers and the economy. Vaccines are essential for regulating the spread of diseases that threaten the health and productivity of animals, thereby reducing economic losses.

The increase in demand for animal protein products is primarily a result of economic growth in emerging economies, which drives the expansion of the livestock sector. This trend has resulted in increased livestock production, which has increased the risk of disease outbreaks, especially in densely populated areas. Governments in emerging economies have instituted vaccination programs to control diseases in recognition of the significance of animal health management in ensuring food security.

The veterinary vaccine growth is driven by the livestock population increase, with the largest share in the animal vaccines industry, combating the prevalence of livestock diseases. In the veterinary vaccine market, the livestock animal segment sees the fastest growth rate. Comprehensive industry trend analysis and detailed analysis reveal promising opportunities.

Key Market Segments

By Type

• Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines
• Others

By Route of Administration

• Oral
• Parenteral
• Intranasal
• Topical

By Disease Type

• Bacterial Diseases
• Viral Diseases
• Parasitic Diseases
• Fungal Diseases

By Animal Type

• Livestock
• Companion
• Aquaculture

Growth Opportunity

The Growing Focus on Animal Welfare and Preventive Healthcare

In recent years, awareness and concern for animal welfare have increased. People have begun to view their pets as members of the family, and their health and well-being are of the utmost importance. The increase in welfare has increased the demand for preventative pet healthcare measures. Simultaneously, advancements in the veterinary field have enabled the development of preventive measures to combat animal diseases. This increasing emphasis on welfare and preventative care is propelling the expansion of the veterinary vaccine market growth.

The Rise in Zoonotic Diseases and Foodborne Illnesses

In recent years, the emergence of zoonotic diseases and foodborne maladies has become a major concern. Zoonotic diseases are transmitted from animals to humans, causing ailments like Avian influenza, BSE, E. coli, and Salmonella. These diseases are a serious concern and have recently caused significant economic damage and deaths. With the rise of zoonotic diseases, there has been an increase in the demand for preventive measures, and the veterinary vaccine market has emerged as a critical factor in controlling and preventing the spread of these diseases.

Advancements in Biotechnology and Genetic Engineering

Significant advances in the veterinary profession have resulted from biotechnology and genetic engineering developments. Now available are vaccines with more targeted and effective outcomes and fewer adverse effects. Vaccines are intended to provide durable protection against a specific disease without overwhelming the immune system. In addition, advances in biotechnology have produced new vaccine development techniques, such as recombinant DNA technology, which make it possible to offer safe and effective vaccines.

Increasing Collaborations and Partnerships Among Key Players in the Market

Due to the growth potential of the veterinary vaccine market, key players have begun collaborating, resulting in the development of novel veterinary vaccines and market growth. These collaborations have created opportunities for new entrants to enter the market in addition to benefiting the dominant companies. Increasing partnerships between stakeholders have also led to the development of new market expansion strategies.

Latest Trends

Development of Novel Vaccines for Emerging Diseases

Emerging diseases pose a significant hazard to healthy animals, and an increasing number of outdated vaccines are ineffective. Therefore, new vaccines that can combat new and emergent threats are required. Companies are investing in research and development to create novel, protective vaccines. These vaccines are created using innovative technologies and platforms that effectively target specific pathogens.

Adoption of Precision Medicine and Personalized Vaccines

Veterinary industry trends, personalized medicine, and precision vaccines are becoming increasingly popular. Veterinary professionals are becoming aware of the significance of individualized treatment plans, and personalized vaccines are becoming an integral part of this. These vaccines are tailored to the specific requirements of each animal, taking into account age, health, and breed. Using precision medicine, veterinarians are able to develop more effective, disease-specific vaccines for animals. The increasing pet ownership is expected to drive demand for pet care products and services, thereby supporting the growth of related sectors such as veterinary vaccines.

Increasing Use of Combination Vaccines

Combination vaccines are gaining popularity within the veterinary industry. With a single injection, these vaccines can protect animals from multiple diseases. Vaccination with combination vaccines is more uncomplicated and cost-effective. These vaccines are practical for pet owners because they necessitate fewer vet visits.

Focus on Animal Health through Animal Nutrition and Supplements

The health of animals is dependent not only on vaccinations but also on their diet and supplements. Animal nutrition and supplements are essential for maintaining their health. There is a new emphasis on providing appropriate nutrition and dietary supplements to animals to ensure their overall health. In response to the rising demand for pet food and animal health supplements, businesses are investing in research and development.

Regional Analysis

During the forecast period, North America is expected to show an impressive presence in veterinary research and development. The region is home to a number of leading pharmaceutical companies, biotech firms, and academic institutions that invest significantly in the development of innovative animal health technologies and vaccines. These technological advancements give North American businesses a market advantage.

North America has established regulatory frameworks for veterinary medicine and vaccines. Before vaccines can be marketed, organizations such as the United States Department of Agriculture (USDA) and the Canadian Food Inspection Agency (CFIA) ensure that they meet safety and efficacy standards. Customers are reassured by these robust regulatory systems, which also facilitate market dominance.

There are numerous veterinary clinics, hospitals, and research facilities in North America. This infrastructure contributes to the dominance of the region by supporting the demand for veterinary vaccines. Moreover, North American veterinarians are highly competent and well-trained, which drives the adoption of vaccines even further. The cattle population represents a significant market for veterinary vaccines aimed at preserving the health and welfare of these livestock creatures.

In North America, key factors contributing to the high pet ownership rate include a large population of canines, cats, and horses, among other companion animals. Additionally, the territory has a substantial livestock animal industry, which includes cattle, poultry, and pigs. The high demand for animal health products, including vaccines, in both the companion animal and livestock industries provides a solid market base for North American veterinary vaccine manufacturers.

The veterinary vaccine market in Asian countries has witnessed significant growth due to rising concerns about animal health and food safety. Increasing livestock production, coupled with growing pet ownership, has driven the demand for vaccines to prevent and control diseases.

Key Regions and Countries

North America

• US
• Canada
• Mexico

Western Europe

• Germany
• France
• The UK
• Spain
• Italy
• Portugal
• Ireland
• Austria
• Switzerland
• Benelux
• Nordic
• Rest of Western Europe

Eastern Europe

• Russia
• Poland
• The Czech Republic
• Greece
• Rest of Eastern Europe

APAC

• China
• Japan
• South Korea
• India
• Australia & New Zealand
• Indonesia
• Malaysia
• Philippines
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Colombia
• Chile
• Argentina
• Costa Rica
• Rest of Latin America

Middle East & Africa

• Algeria
• Egypt
• Israel
• Kuwait
• Nigeria
• Saudi Arabia
• South Africa
• Turkey
• United Arab Emirates
• The rest of Middle East Asia

Key Players Analysis

Zoetis Inc., a global animal health company that provides a vast selection of vaccines, medicines, and diagnostic products for a variety of animal species, is one of the prominent players in the veterinary vaccine market. The company invests significantly in R&D to introduce new products to the market and has a strong presence on the market.

Merck & Co., Merck Animal Health, another significant player in the veterinary vaccine market, develops and manufactures vaccines for a variety of veterinary diseases. Poultry vaccines, livestock, cattle vaccines, and companion animals are among the poultry products offered by the company. Additionally, it is actively involved in the development of novel technologies for the production of safer and more effective vaccines.

Bayer AG is another major player in the veterinary vaccine market, with a comprehensive portfolio of products for the prevention and treatment of animal diseases. Animal health products are in high demand in emerging markets, where the company has a significant presence. Also, Boehringer Ingelheim, Elanco, Ceva, and Phibro Animal Health Corporation are other major Industry players in this market.

Top Key Players in the Veterinary Vaccine Market

• Zoetis
• Indian Immunologicals Ltd
• Merck & Co.
• Boehringer Ingelheim International GmbH
• Bayer Pharma Ag
• Elanco
• Ceva Santé Animale
• Phibro Animal Health Corporation
• Virbac SA
• Sanofi (Merial Animal Health)
• Intas Pharmaceuticals Ltd
• Neogen Corporation
• Romvac Company S.A
• Dechra Pharmaceuticals PLC
• Hygieia Biological Laboratories

Recent Development

• In July 2023, a new regulation by the Russian watchdog, Rosselhoznadzor, will mandate that all imported poultry vaccine strains be stored in Russian scientific institutions.
• In April 2023, The US FDA amended the Emergency Use Authorizations (EUAs) for monovalent messenger ribonucleic acid (mRNA) COVID-19 vaccines from Moderna and Pfizer/BioNTech.
• In January 2023, Dalan Animal Health, a biotech company specializing in insect health, was granted a conditional license by the U.S. Department of Agriculture (USDA) for a vaccine aimed at protecting honeybees against
• In 2021, Zoetis will release a vaccine against the Porcine Epidemic Diarrhea Virus (PEDv) in the United States. In recent years, PEDv has been a significant concern for pig farmers, as it causes severe diarrhea and high piglet mortality rates. With their new vaccine, Zoetis aims to assist in protecting pork producers from this fatal disease.

Report Scope